Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Compagnon

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Trials|January 1, 2016
Biliary reconstruction with or without an intraductal removable stent in liver transplantation: study protocol for a randomized controlled trialClaire Goumard, Marine Cachanado, Astrid Herrero, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 25, 2016
Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver TransplantationNicola de'Angelis, Filippo Landi, Marco Nencioni, et al.
Transplantation Reviews (Orlando, Fla.)|June 25, 2024
Effect of islet alone or islets after kidney transplantation on quality of life in type 1 diabetes: A systematic reviewKarim Gariani, Andrea Peloso, Vasiliki Galani, et al.
Revue Medicale Suisse|September 10, 2019
[Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner]Sarah Henchoz, Montserrat Fraga, Anne-Catherine Saouli, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 19, 2015
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgeryChetana Lim, Philippe Compagnon, Mylène Sebagh, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 26, 2017
Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysisChetana Lim, Hiroji Shinkawa, Kiyoshi Hasegawa, et al.
Annals of Surgery|February 19, 2021
Renoportal Anastomosis During Liver Transplantation in Patients With Portal Vein Thrombosis: First Long-term Results From a Multicenter StudyDaniel Azoulay, Cristiano Quintini, Michel Rayar, et al.
World Journal of Gastroenterology|December 5, 2006
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patientsThomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, et al.
International Journal of Cancer|August 30, 2018
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinomaBenoit Rousseau, Aude Guillemin, Christophe Duvoux, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2014
Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experiencePhilippe Compagnon, Philippe Metzler, Didier Samuel, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Trials|January 1, 2016
Biliary reconstruction with or without an intraductal removable stent in liver transplantation: study protocol for a randomized controlled trialClaire Goumard, Marine Cachanado, Astrid Herrero, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 25, 2016
Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver TransplantationNicola de'Angelis, Filippo Landi, Marco Nencioni, et al.
Transplantation Reviews (Orlando, Fla.)|June 25, 2024
Effect of islet alone or islets after kidney transplantation on quality of life in type 1 diabetes: A systematic reviewKarim Gariani, Andrea Peloso, Vasiliki Galani, et al.
Revue Medicale Suisse|September 10, 2019
[Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner]Sarah Henchoz, Montserrat Fraga, Anne-Catherine Saouli, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 19, 2015
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgeryChetana Lim, Philippe Compagnon, Mylène Sebagh, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 26, 2017
Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysisChetana Lim, Hiroji Shinkawa, Kiyoshi Hasegawa, et al.
Annals of Surgery|February 19, 2021
Renoportal Anastomosis During Liver Transplantation in Patients With Portal Vein Thrombosis: First Long-term Results From a Multicenter StudyDaniel Azoulay, Cristiano Quintini, Michel Rayar, et al.
World Journal of Gastroenterology|December 5, 2006
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patientsThomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, et al.
International Journal of Cancer|August 30, 2018
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinomaBenoit Rousseau, Aude Guillemin, Christophe Duvoux, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2014
Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experiencePhilippe Compagnon, Philippe Metzler, Didier Samuel, et al.
Pageof 10